Unsafe Prescribing is a System Problem, (Not Just a Provider Problem)
Last updated: 3/24/26
Part 3 of 4: Learn how to pressure leadership to adopt clinic-wide policies for benzos, stimulants, Hypotics and opioids to protect your license.
Parts 1 and 2 of this series covered what to do when you inherit an unsafe prescribing panel and what to expect when you refuse to continue it. This article is about the question underneath both of those: why does this situation exist at all, and what does it actually take to change it?
The answer is not a better-trained provider. The answer is organizational accountability. And the story of how that accountability finally arrived in my situation is not a satisfying one.
How does an unsafe prescribing culture form in a clinic?
Answer capsule: Unsafe prescribing cultures form when leadership prioritizes patient satisfaction over clinical standards and absorbs no personal consequence for the gap between the two.
When a clinic allows a provider to prescribe chronic benzodiazepines, opioids outside the standard of care, or complex psychiatric regimens beyond the provider's scope, it is not because no one noticed. It is because the arrangement was convenient.
Patients were satisfied. Complaints were low. The provider was productive. Leadership did not have to manage the clinical risk because the risk was sitting entirely on the provider's license, not on the organization's books.
In my situation, my medical director told me directly that the previous provider's prescribing was unsafe. He said this while simultaneously pressuring me not to be disruptive about my refusal to continue it. Those two positions cannot coexist. What they reveal is that leadership understood the clinical problem and had made a deliberate choice to leave it in place because addressing it would be costly and uncomfortable.
That is not a provider problem. That is an organizational decision.
Why can't one provider fix an unsafe prescribing culture alone?
Answer capsule: Because the organization can redirect the problem to another provider. Individual refusal removes you from the liability chain. It does not change the chain.
When I refused to continue the inherited prescribing practices, my medical director took the patients himself. The prescribing continued under a different name for six weeks. Then he redistributed those patients to other newer providers on staff.
Here is what he discovered: word had gotten around. Those providers had watched what happened when I refused, and they refused too. One of them told me he had been trying to raise this exact problem for months before I arrived. No one had listened to him.
His experience illustrates the first reason individual refusal is not enough: when only one person refuses, the organization routes around the refusal. The liability moves to someone else. The culture does not change.
His months of unheeded warnings illustrate the second reason: individual escalation to leadership does not produce structural change when leadership has already decided the arrangement is acceptable. One voice raising a clinical concern is easy to dismiss. A critical mass of providers all refusing the same thing is a different problem.
What does structural change in a prescribing culture actually require?
Answer capsule: Formal clinic-wide policy, adopted by leadership and applied to every provider. Not an individual boundary, not a verbal agreement. Written policy with clinical standards attached.
In my situation, structural change finally arrived when enough providers had refused that the organization could not route around the problem anymore. The directors of pharmacy, behavioral health, and primary care held a meeting. They introduced new policies and practice guidelines that were, for the first time, actually evidence-based.
That meeting was the outcome that should have happened before any individual provider was put in the position of cleaning up a panel alone. It did not happen then because there was no pressure on leadership to act. It happened when the pressure became unavoidable.
If you are in a clinic with an unsafe prescribing culture and you want structural change, the path is policy, not persuasion. Leadership responds to liability and to the operational disruption of having multiple providers refuse the same category of inappropriate requests. Frame every conversation with leadership around those two things:
The financial and legal exposure the clinic is carrying by having providers manage out-of-scope cases
The operational reality that providers are already declining these requests, and that a written policy protects the clinic as well as the providers
If leadership asks you verbally to continue prescribing in a way that falls outside your scope or the current standard of care, request that in writing. A written request to continue unsafe prescribing is documentation of the organization's awareness of the risk. It tends to produce a very different response than the verbal conversation did.
What role does behavioral health play in resolving an inherited prescribing problem?
Answer capsule: Behavioral health referrals are both a clinical necessity and a structural argument. They document that the patient's condition requires a level of care the primary care setting was never designed to provide.
The majority of patients on chronic benzodiazepines, stimulants, or hypnotics have underlying conditions -- anxiety, ADHD, insomnia -- that were managed with medication because behavioral health was never brought in. The prescription became a substitute for a referral that should have happened years earlier.
Proactive behavioral health referrals do three things. They route the patient toward appropriate care. They document that the primary care setting is not the right venue for this management. And they create a record that you recognized the clinical complexity and responded to it correctly, which matters if the transition becomes contentious.
For patients on hypnotics specifically, document that CBT-I was offered before any decision is made about continuing long-term medication. That documentation is your defense if the prescribing decision is ever questioned.
What does professional alignment mean when the organization won't change?
Answer capsule: If the organization refuses to adopt clinical standards, you have two options: protect yourself within the structure you have, or leave it. Both are legitimate. Neither is a failure.
There is a version of this situation where the policy meeting happens while you are still there and still invested. That version exists. It did not happen in my case.
By the time the directors of pharmacy, behavioral health, and primary care presented those evidence-based guidelines, my medical director was riding out his notice of resignation. So was I. The organization had ignored the provider who raised the alarm first. It had pressured others into maintaining a prescribing culture it privately acknowledged was wrong. It could not terminate me because I was on solid clinical ground, but it could make the environment difficult enough that staying required more than I had left to give.
That is the realistic version of professional alignment. The institution changed. The change came too late for the people who forced it.
If you conclude that the organization's values are not compatible with safe practice, that conclusion is valid. Leaving is not a failure. It is an accurate read of the situation. If you choose to stay and work toward structural change, the strategy is documentation, coalition, and persistent escalation through formal channels rather than individual confrontation. Both paths require the same foundation: meticulous records of what you refused, why, and what happened when you did.
What can you do with this today?
Answer capsule: Identify whether the problem you are managing is a policy gap or a values gap. The response to each is different.
A policy gap means clinical standards do not exist in writing at your organization. They may be enforceable if you push for them. The path is a formal conversation with leadership framed around liability, supported by documentation of the clinical risks the current arrangement creates.
A values gap means leadership knows the standards, has been told about the standards, and has chosen to prioritize operational convenience over them. That gap does not close through individual effort. The question it asks is whether you are willing to absorb the cost of staying in a structure that will not change, or whether it is time to evaluate your options.
Knowing which problem you have changes what you do next. A single honest conversation with your medical director or administrator (framed around the clinic's liability, not your personal objections) will usually tell you which one it is.
Get the Free NP Negotiation & Contract Protection Guide
If you are evaluating whether your current organization is structured for safe practice, or what your options look like if it is not, the NP Negotiation & Contract Protection Guide covers the job-level decisions that follow from that assessment.
Read This Whole Series
Part 1: When Inheriting a Patient Panel Means Inheriting Unsafe Prescribing
Part 2: When Safe Practice Makes You the "Difficult" Provider
Part 4: How to Leave a Toxic Practice (or Survive It) with Your Professional Identity Intact
The Refill Request Message Master Kit is a targeted resource for primary care providers designed to streamline medication management. It provides pre-written, customizable templates and a comprehensive workflow guide to efficiently respond to, approve, or reject refill requests. Quickly communicate critical decisions, ensure patient safety with re-evaluation protocols, and reduce the time spent managing this high-volume, administrative task to reclaim your evenings and weekends.
